Ammonium 2,2'-((2-(bis(carboxymethyl)amino)ethyl)azanediyl)diacetate hydrate

Catalog No. :
ACNOJH729
CAS No. :
304675-80-7
Molecular Formula :
C10H24N4O9
Molecular Weight :
344.32

IUPAC Name:ammonium 2,2'-((2-(bis(carboxymethyl)amino)ethyl)azanediyl)diacetate hydrate

Ammonium 2,2'-((2-(bis(carboxymethyl)amino)ethyl)azanediyl)diacetate hydrate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameAmmonium 2,2'-((2-(bis(carboxymethyl)amino)ethyl)azanediyl)diacetate hydrate
IUPAC Nameammonium 2,2'-((2-(bis(carboxymethyl)amino)ethyl)azanediyl)diacetate hydrate
MDL No.MFCD00150463
Molecular FormulaC10H24N4O9
Molecular Weight344.32
SMILESO=C([O-])CN(CC([O-])=O)CCN(CC(O)=O)CC(O)=O.[H]O[H].[NH4+].[NH4+]
InChI KeyWRSUMHYBOYWMTD-UHFFFAOYSA-N
SynonymAKOS025295100 | Ammonium 2,2'-((2-(bis(carboxymethyl)amino)ethyl)azanediyl)diacetate hydrate | Ammonium 2,2'-({2-[bis(carboxymethyl)amino]ethyl}azanediyl)diacetate--water (2/1/1) | Glycine, N,N'-1,2-ethanediylbis[N-(carboxymethyl)-, diammonium salt, monoh
CAS No.304675-80-7
PubChem CID18446095

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P301+P312-P302+P352-P304+P340-P305+P351+P338

Synthetic Route by SureRoute

1. ACNOJH729 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPTFB326 route compound structure diagram
    ACPTFB3261068-52-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNOJH729 route product structure diagram
    ACNOJH729304675-80-7
Inquiry

2. ACNOJH729 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNOJH729 route product structure diagram
    ACNOJH729304675-80-7
Inquiry

Comments (0)